Active Ingredient(s): Amlodipine + Aliskiren + Hydrochlorothiazide
FDA Approved: December 21, 2010
Category: Blood Pressure

Amturnide Overview

The drug combination aliskiren/amlodipine/hydrochlorothiazide (INNs, trade name Amturnide) is an antihypertensive approved by the U.S. Food and Drug Administration (FDA) on December 21, 2010.[1] References ^ Amturnide approval letter. U.S. Food and Drug Administration (FDA). External links Amturnide full prescribing information v t e Antihypertensives: agents acting on the renin–angiotensin system (C09) ACE inhibitors ("-pril") Sulfhydryl-containing: Captopr...

Read more Amturnide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Amturnide Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Amlodipine + Aliskiren + Hydrochlorothiazide
  • Tablet: 150 + 5 + 12.5mg, 150mg + 5mg + 12.5mg, 300mg + 10mg + 12.5mg, 300mg + 10mg + 25mg, 300mg + 5mg + 12.5mg, 300mg + 5mg + 25mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (86 results)